Fortress Biotech Inc.

FBIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.41

-$0.10 (-3.98%)

At close: Sep 21, 2026, 4:00 PM ET

$2.44

+$0.03 (+1.24%)

Pre-market: Sep 22, 2026, 8:19 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.98%

(1D)

Rating

Updated: Sep 2, 2026

54.5

Fundamentals Strong

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $80.06M

1D Range

2.40 2.51

52W Range

2.18 4.53

Valuation (TTM)

PE 0.91

PB 0.49

EV/EBITDA -0.43

Valuation (NTM)

Forward PE 0.52

Forward PEG -0.01

Price Target $5

Cash Flow

FCF Yield 231.3%

SBC Adj. FCF Yield 224.3%

SBC Impact -3.0%

Margins

Gross Margin 62.5%

Operating Margin -43.4%

FCF Margin 274.0%

Growth (CAGR)

Revenue 3Y | 5Y 2.5% | 5.1%

Dil EPS 3Y | 5Y 408.8% | 73.8%

FCF 3Y | 5Y 8380.0% | 115.2%

Returns

ROA 35.3%

ROE 103.5%

ROIC -10.8%

Financial Health

Net Cash

$143.26M

Current Ratio 3.96

Interest Coverage -3.27

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently of...

Sector Healthcare

Industry Biotechnology

Employees 78

IPO Date Nov 16, 2011

Website www.fortressbiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 16, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+107.47%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞